Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta-analysis.

Folate-pathway gene polymorphisms have been implicated in several cancers and investigated inconclusively in relation to prostate cancer. We conducted a systematic review, which identified nine case-control studies (eight included, one excluded). We also included data from four genome-wide associati...

Full description

Bibliographic Details
Main Authors:	Collin, S, Metcalfe, C, Zuccolo, L, Lewis, S, Chen, L, Cox, A, Davis, M, Lane, J, Donovan, J, Smith, G, Neal, D, Hamdy, F, Gudmundsson, J, Sulem, P, Rafnar, T, Benediktsdottir, K, Eeles, R, Guy, M, Kote-Jarai, Z, Morrison, J, Al Olama, A, Stefansson, K, Easton, D, Martin, R
Format:	Journal article
Language:	English
Published:	2009

Similar Items

Association of Folate-Pathway Gene Polymorphisms with the Risk of Prostate Cancer: a Population-Based Nested Case-Control Study, Systematic Review, and Meta-analysis (vol 18, pg 2528, 2009)
by: Collin, S, et al.
Published: (2010)

Alcohol consumption and PSA-detected prostate cancer risk--a case-control nested in the ProtecT study.
by: Zuccolo, L, et al.
Published: (2013)

Associations of folate, vitamin B12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer.
by: Collin, S, et al.
Published: (2010)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
by: Collin, S, et al.
Published: (2009)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
by: Collin, S, et al.
Published: (2009)

Common genetic variants associated with disease from genome-wide association studies are mutually exclusive in prostate cancer and rheumatoid arthritis.
by: Orozco, G, et al.
Published: (2013)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
by: Turner, E, et al.
Published: (2011)

Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis.
by: Collin, S, et al.
Published: (2010)

Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness.
by: Lose, F, et al.
Published: (2013)

Detection of prostate cancer in unselected young men: prospective cohort nested within a randomised controlled trial.
by: Lane, J, et al.
Published: (2007)

Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
by: Batra, J, et al.
Published: (2011)

Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified.
by: Down, L, et al.
Published: (2009)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
by: Avery, K, et al.
Published: (2007)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
by: Avery, K, et al.
Published: (2008)

PTGS2-899G>C and prostate cancer risk: a population-based nested case-control study (ProtecT) and a systematic review with meta-analysis.
by: Murad, A, et al.
Published: (2009)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
by: Down, L, et al.
Published: (2011)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
by: Macefield, R, et al.
Published: (2009)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
by: Down, L, et al.
Published: (2011)

Germline DNA repair gene mutations in young-onset prostate cancer cases in the UK: evidence for a more extensive genetic panel
by: Leongamornlert, D, et al.
Published: (2019)

Genome-wide association study identifies new prostate cancer susceptibility loci
by: Schumacher, F, et al.
Published: (2011)

Genome-wide association study identifies new prostate cancer susceptibility loci.
by: Schumacher, F, et al.
Published: (2011)

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
by: Metcalfe, C, et al.
Published: (2008)

Evaluation of association of HNF1B variants with diverse cancers: collaborative analysis of data from 19 genome-wide association studies.
by: Elliott, K, et al.
Published: (2010)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
by: Simpkin, A, et al.
Published: (2013)

Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study.
by: Brunner, C, et al.
Published: (2016)

Impact of prostate cancer testing: an evaluation of the emotional consequences of a negative biopsy result.
by: Macefield, R, et al.
Published: (2010)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
by: Avery, K, et al.
Published: (2012)

Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy
by: Avery, K, et al.
Published: (2012)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
by: Hamdy, F, et al.
Published: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
by: Lane, J, et al.
Published: (2007)

Folate and Inflammation – links between folate and features of inflammatory conditions
by: Patrice Jones, et al.
Published: (2019-12-01)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
by: Rosario, D, et al.
Published: (2008)

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.
by: Lophatananon, A, et al.
Published: (2017)

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.
by: Eeles, R, et al.
Published: (2009)

Decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
by: Avery, K, et al.
Published: (2008)

It's not just what you say, it's also how you say it: opening the 'black box' of informed consent appointments in randomised controlled trials.
by: Wade, J, et al.
Published: (2009)

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study.
by: Tom Callender, et al.
Published: (2019-12-01)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.
by: Rosario, D, et al.
Published: (2012)

Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: Prospective evaluation within ProtecT study
by: Rosario, D, et al.
Published: (2012)